Table 4.
Outcome comparison between patients with suspected VRI retrospectively (n = 67) and prospectively (n = 66) included before and after the introduction of the broad range eubacterial polymerase chain reaction of cerebrospinal fluid
| GOSE | Retrospective group (n = 67) | Prospective group (n = 66) | p value |
|---|---|---|---|
| Unfavorable (1–4) | 32 (47.8) | 40 (60.1) | 0.881 |
| 1 | 9 (16.7) | 10 (15.2) | |
| 2 | 4 (7.4) | 4 (6.1) | |
| 3 | 10 (18.5) | 13 (19.7) | |
| 4 | 9 (16.7) | 13 (19.7) | |
| 5 | 12 (22.2) | 17 (25.8) | |
| 6 | 9 (16.7) | 4 (6.1) | |
| 7 | 1 (1.9) | 3 (4.5) | |
| 8 | 0 (0.0) | 2 (3.0) |
Outcome was assessed with the Glasgow Outcome Scale extended (GOSE) at 3 months. Percentages are shown in parentheses
VRI, ventriculostomy-related infection